Arcutis Biotherapeutics, Inc.
Total Trades
200
Buys
12
Sells
137
Largest Trade
N/A
Insiders
21
Institutional Funds
225
Inst. Value
$1M+
Activist Filings
37
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Welgus Howard G. | Director | SELL | $100K–$500K | 10K | $13.37 | Jun 20, 2025 |
| Heron Patrick J | Director | BUY | $15K–$50K | 3K | $13.08 | Jun 17, 2025 |
| Heron Patrick J | Director | BUY | $15K–$50K | 2K | $13.34 | Jun 6, 2025 |
| Matsuda Masaru | See Remarks | SELL | $15K–$50K | 2K | $13.78 | May 30, 2025 |
| Heron Patrick J | Director | BUY | $50K–$100K | 5K | $13.65 | May 23, 2025 |
| Edwards Larry Todd | See Remarks | SELL | $100K–$500K | 7K | $14.07 | May 20, 2025 |
| Heron Patrick J | Director | BUY | $15K–$50K | 3K | $13.62 | May 19, 2025 |
| Heron Patrick J | Director | BUY | $100K–$500K | 9K | $13.76 | May 15, 2025 |
| Heron Patrick J | Director | BUY | $50K–$100K | 6K | $13.60 | May 13, 2025 |
| Burnett Patrick | See Remarks | SELL | $50K–$100K | 4K | $13.59 | May 9, 2025 |
| Matsuda Masaru | See Remarks | SELL | $50K–$100K | 5K | $15.20 | May 5, 2025 |
| Watanabe Todd Franklin | See Remarks | SELL | $100K–$500K | 11K | $15.19 | May 5, 2025 |
| Burnett Patrick | See Remarks | SELL | $15K–$50K | 3K | $15.19 | May 5, 2025 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 10K | $14.64 | May 5, 2025 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 10K | $15.12 | Apr 3, 2025 |
| Topper David Joseph | CFO | SELL | $100K–$500K | 10K | $15.80 | Apr 3, 2025 |
| Watanabe Todd Franklin | See Remarks | SELL | $50K–$100K | 4K | $17.55 | Mar 26, 2025 |
| Watanabe Todd Franklin | See Remarks | SELL | $15K–$50K | 1K | $17.61 | Mar 20, 2025 |
| Burnett Patrick | See Remarks | EXERCISE | N/A | 17K | — | Mar 17, 2025 |
| Burnett Patrick | See Remarks | SELL | $500K+ | 61K | $14.99 | Mar 17, 2025 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 10K | $14.67 | Jan 6, 2025 |
| Burnett Patrick | See Remarks | SELL | $15K–$50K | 2K | $14.00 | Dec 31, 2024 |
| Watanabe Todd Franklin | See Remarks | SELL | $100K–$500K | 15K | $15.17 | Dec 24, 2024 |
| Edwards Larry Todd | See Remarks | BUY | $1K–$15K | 1K | $7.11 | Dec 3, 2024 |
| Matsuda Masaru | See Remarks | BUY | $15K–$50K | 6K | $3.28 | Dec 3, 2024 |
| Welgus Howard G. | Director | SELL | $100K–$500K | 10K | $12.51 | Dec 3, 2024 |
| Watanabe Todd Franklin | See Remarks | BUY | $15K–$50K | 6K | $3.52 | Dec 3, 2024 |
| Burnett Patrick | See Remarks | EXERCISE | N/A | 16K | — | Nov 26, 2024 |
| Burnett Patrick | See Remarks | SELL | $100K–$500K | 16K | $10.14 | Nov 26, 2024 |
| Matsuda Masaru | See Remarks | SELL | $15K–$50K | 2K | $9.68 | Nov 20, 2024 |
| Matsuda Masaru | See Remarks | GRANT | N/A | 5K | — | Nov 20, 2024 |
| Burnett Patrick | See Remarks | EXERCISE | N/A | 18K | — | Nov 19, 2024 |
| Burnett Patrick | See Remarks | SELL | $500K+ | 69K | $10.29 | Nov 19, 2024 |
| Curran Terrie | Director | SELL | $50K–$100K | 9K | $10.85 | Nov 13, 2024 |
| Matsuda Masaru | See Remarks | SELL | $15K–$50K | 5K | $8.68 | Nov 5, 2024 |
| Watanabe Todd Franklin | See Remarks | SELL | $100K–$500K | 14K | $8.68 | Nov 5, 2024 |
| Welgus Howard G. | Director | SELL | $50K–$100K | 10K | $8.65 | Nov 5, 2024 |
| Burnett Patrick | See Remarks | SELL | $100K–$500K | 15K | $8.68 | Nov 5, 2024 |
| Welgus Howard G. | Director | SELL | $50K–$100K | 10K | $9.26 | Oct 3, 2024 |
| Edwards Larry Todd | SVP Chief Commerci… | SELL | $15K–$50K | 4K | $10.01 | Oct 3, 2024 |
| Topper David Joseph | CFO | GRANT | N/A | 60K | — | Sep 26, 2024 |
| Topper David Joseph | CFO | SELL | $100K–$500K | 12K | $9.48 | Sep 26, 2024 |
| Burnett Patrick | See Remarks | SELL | $1K–$15K | 2K | $8.29 | Aug 21, 2024 |
| Welgus Howard G. | Director | SELL | $50K–$100K | 10K | $9.31 | Jul 2, 2024 |
| Welgus Howard G. | Director | EXERCISE | $15K–$50K | 10K | $1.68 | Jul 2, 2024 |
| Welgus Howard G. | Director | SELL | $50K–$100K | 10K | $8.01 | Jun 6, 2024 |
| Welgus Howard G. | Director | EXERCISE | $15K–$50K | 10K | $1.68 | Jun 6, 2024 |
| Burnett Patrick | See Remarks | EXERCISE | N/A | 23K | — | May 31, 2024 |
| Burnett Patrick | See Remarks | SELL | $500K+ | 73K | $8.73 | May 31, 2024 |
| Matsuda Masaru | See Remark | SELL | $15K–$50K | 2K | $9.01 | May 29, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 225 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9.9M | $1M+ | SH |
| Rubric Capital Management LP | 8.3M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 5.6M | $1M+ | SH |
| STATE STREET CORP | 5.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $1M+ | SH |
| Ensign Peak Advisors, Inc | 1.9M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.5M | $1M+ | SH |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.4M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.0M | $1M+ | SH |
| GW&K Investment Management, LLC | 939K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 914K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 900K | $1M+ | SH |
| Perpetual Ltd | 824K | $1M+ | SH |
| Candriam S.C.A. | 803K | $1M+ | SH |
| VANGUARD GROUP INC | 763K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 700K | $1M+ | SH |
| FISHMAN JAY A LTD/MI | 565K | $1M+ | SH |
| MPM BioImpact LLC | 531K | $1M+ | SH |
| Cormorant Asset Management, LP | 500K | $1M+ | SH |
| Capitolis Liquid Global Markets LLC | 500K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
6.8%
8.3M shares
SC 13G/A · Feb 13, 2026
5.7%
7.1M shares
SC 13G/A · Jan 30, 2026
5.5%
6.8M shares
SC 13G/A · Oct 6, 2025
10.2%
12.3M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Aug 20, 2025
7.3%
8.8M shares
SC 13G/A · Aug 14, 2025
4.2%
5.0M shares
SC 13G/A · May 15, 2025
10.1%
12.0M shares
SC 13G/A · May 15, 2025
5.7%
6.7M shares
SC 13G/A · May 8, 2025
9.6%
11.4M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
0.2%
247K shares
SC 13G/A · Nov 13, 2024
9.4%
11.0M shares
SC 13G/A · Nov 8, 2024
7.7%
9.0M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G/A · Nov 6, 2024
3.4%
4.0M shares
SC 13G/A · Oct 22, 2024
7.7%
9.0M shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · Mar 6, 2024
7.8%
8.8M shares
Jennison Associates LLC IRS Identification #52-2069785 (formerly 13-2631108)
SC 13G/A · Mar 6, 2024
10.8%
12.1M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
4.9M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2024
10.0%
9.5M shares
SC 13G/A · Feb 13, 2024
6.7%
6.3M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G · Feb 12, 2024
6.5%
6.1M shares
SC 13G · Feb 12, 2024
7.0%
6.6M shares
Point72 Asset Management, L.P.
SC 13G · Jan 31, 2024
5.1%
4.8M shares
SC 13G · Jan 29, 2024
6.3%
5.9M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 23, 2024
1.6%
0 shares
SC 13G · Nov 16, 2023
7.6%
7.1M shares
SC 13G/A · Nov 13, 2023
3.8%
3.6M shares
SC 13G/A · Nov 7, 2023
4.1%
3.9M shares
Suvretta Capital Management, LLC
SC 13G · Oct 30, 2023
10.0%
9.6M shares
Frazier Life Sciences VIII, L.P. 2.
SC 13D/A · Oct 26, 2023
9.3%
8.8M shares
SC 13G/A · Feb 3, 2023
8.6%
5.2M shares
SC 13D/A · Aug 26, 2022
4.7%
2.8M shares
Frazier Life Sciences VIII, L.P.
SC 13D/A · Aug 9, 2022
14.5%
8.7M shares
Bain Capital Life Sciences Fund, L.P.
SC 13D/A · Aug 8, 2022
4.5%
2.7M shares
SC 13D/A · Aug 8, 2022
5.4%
3.1M shares
SC 13D/A · Jun 28, 2022
6.9%
3.5M shares
Bain Capital Life Sciences Fund, L.P.
SC 13D/A · May 27, 2022
5.3%
2.7M shares
SC 13D/A · Apr 8, 2022
7.6%
3.8M shares